GeneGlobe ID: UHS-009Z | Cat. No.: | QIAseq Multimodal Panels

QIAseq Multimodal Human Leukemia Panel

Kit containing ALL reagents (except indexes) for multimodal (DNA and RNA) sequencing

Select a variant to see the price

Product Specification

Target List

For DNA sequencing, covers all exons in all known transcripts of targeted genes based on the Human GRCh37 / hg19 genome build. For RNA sequencing, covers specific sides of specific exons of the targeted genes based on the Human GRCh38 genome build.

Acute Lymphoblastic Leukemia (ALL)
ASXL2, ATM, BRAF, CALR, CDKN2A (P16INK4A), CREBBP (CBP), CRLF2 (TSLPR), CSF3R (GM-CSFR), CTCF, DNM2, EGFR (ERBB1), EP300, FBXW7, GATA2, HNRNPK, HRAS, IKZF3, IL7R, KDM6A, KDR (VEGFR3), KMT2C, LRRC4, MAP2K1, MLH1, MSH2, MSH6, NOTCH1, NTRK3, PAX5, PDGFRA, PMS2, PRAMEF2, PTEN, RELN, SMARCB1, ABL1, ABL2 (ARG), ACTN4, AFF1, AFF3, AFF4, AGGF1, ASNS, ATF7IP, AUTS2, BCL9, BCR, BTBD18, CASC5, CREBBP (CBP), CRLF2 (TSLPR), CSF1R, DDX3X, EBF1, ELL, ELN, EML1, EP300, EPS15, ESRRB, ETV6, EWSR1, FGFR1, FGFR1OP, FLT3, FOXO4, FOXP1, FRYL, GAS7, GPHN, HLF, HNRNPUL1, INPP5D, JAK2, KMT2A, KMT2E, LNP1, MAML2, MEF2D, MLLT1, MLLT10, MLLT3, AFDN, MN1, MNX1, MYC, NCOA2, NOTCH1, NUP214, NUP98, P2RY8, PAX5, PBX1, PCM1, PDGFRB, PICALM, PML, PRDM16, RAP1GDS1, RARA, RCSD1, RUNX1 (AML1), SALL2, SET, SFPQ, SPI1, SSBP2, STIL, STMN1, TAF15, TAL1, TCF3, TCF7, TET1, USP9X, ZBTB16, ZMIZ1, ZMYM2, ZNF384, ZNF521
Acute Myeloid Leukemia (AML)
ANKRD26, ASXL1, ATM, BCOR, BCORL1, BIRC3 (c-IAP2), BRAF, C17orf97, CALR, CARD11, CBLC, CDKN2A (P16INK4A), CEBPA, CHEK2 (RAD53), CREBBP (CBP), CSF1R, CSF3R (GM-CSFR), CTCF, DAXX, DDX41, DNM2, DNMT1, ELANE, EP300, FLRT2, FLT3, GATA1, GATA2, HNRNPK, IDH1, IDH2, IKZF1, IL7R, JAK1, JAK3, KDM6A, KDR (VEGFR3), KIT (CD117), KMT2A, KMT2C, KMT2D, KRAS, LRRC4, MAP2K1, MPL, MSH6, MYC, NBN, NOTCH1, NPM1, NRAS, NSD1, NTRK3, OR13H1, OR8B12, P2RY2, PBRM1, PCDHB1, PDGFRA, PHF6, PPM1D, PRAMEF2, PRPF8, PTEN, PTPN11, RAD21, RET, RUNX1 (AML1), SF1, SF3A1, SMARCB1, SMC1A, SMC3, SRP72, SRSF2, STAG2, STXBP2, U2AF1, U2AF2, WT1, ABI1, ABI2, ABL1, AFF1, AFF4, ALK, ANLN, ARHGAP26, ARHGEF12, BCOR, BCR, CASC5, CBFA2T3, CBFB, CBL, CCDC88C, CEP170B, CHD1, CHIC2, CREBBP (CBP), DAB2IP, DDX10, DEK, DHH, ELL, EP300, EPS15, ERG, ETV6, FGFR1, FIP1L1, FLNA, FNBP1, FOXO3, FOXO4, FRYL, FUS, GAS7, GATA1, GLIS2, GPHN, HAUS1, HOXA9, HOXC11, HOXC13, HOXD13, IRF2BP2, JAK2, KAT6A, KDM5A, KIAA1524, KMT2A, LASP1, LNP1, LPP, LYN, MAML2, MECOM, MKL1, MLF1, MLLT1, MLLT10, MLLT11, MLLT3, AFDN, MLLT6, MN1, MNX1, MYB, MYH11, MYO1F, NCKIPSD, NCOA2, NF1, NPM1, NSD1, NTRK3, NUMA1, NUP214, NUP98, PBX1, PCM1, PDGFRA, PDGFRB, PDS5A, PHF23, PICALM, PML, PRDM16, PRRX1, PSIP1, PTPRR, RANBP2, RARA, RBM15, RHEBL1, RPL22, RPN1, RUNX1 (AML1), RUNX1T1, SARNP, SEPT2, SEPT5, SEPT6, SEPT9, SET, SH3GL1, SORBS2, STAT5B, TAF15, TCF3, TET1, TFG, TOP1, TOP3A, TRIP11, UBA2, USP42, WHSC1L1, WTIP, ZBTB16, ZFYVE19, ZNF384
Chronic Lymphocytic Leukemia (CLL)
ADA, BIRC3 (c-IAP2), BLM, BRAF, CALR, CHEK2 (RAD53), CSF3R (GM-CSFR), KCNA4, KLHL6, KMT2C, MAP2K1, NBN, NPAT, NTRK3, OR13H1, OR8B12, PRAMEF2, SRP72, TAL1, TERT, TUBA3C, WAS, WRN, MYC, NOTCH1
Chronic Myeloid Leukemia (CML)
ABL1, CALR, CDKN2A (P16INK4A), CEBPA, CREBBP (CBP), CSF1R, CSF3R (GM-CSFR), FBXW7, GATA2, KDM6A, MSH2, MSH6, RB1, SMC1A, TP53 (p53), ABL1, BCR, CCDC88C, ETV6, JAK2, MECOM, MN1, NDE1, PCM1, PDGFRB, RUNX1 (AML1)
Chronic Myelomonocytic Leukemia (CMML)
CALR, CEBPA, CSF1R, CSF3R (GM-CSFR), HRAS, KMT2C, LUC7L2, SRSF2, CREBBP (CBP), ELL, ETV6, KMT2A, MN1
Chronic Neutrophilic Leukemia (CNL)
CALR, CSF3R (GM-CSFR)
Multiple Myeloma
ATM, BCL6, BCR, BIRC3 (c-IAP2), BRAF, CDKN2A (P16INK4A), CEBPA, EGFR (ERBB1), FBXW7, GJB3, HRAS, KDM6A, MYC, NOTCH1, PTEN, SH2D1A, SMARCB1
Myelodysplastic Syndromes (MDS)
ATRX, CALR, CDKN2A (P16INK4A), CEBPA, CSF1R, CSF3R (GM-CSFR), EP300, ETNK1, GNAS, HRAS, KDM6A, KMT2A, KMT2C, RAD21, RB1, SETBP1, SF1, SF3A1, SMC3, SRSF2, STAG2, U2AF1, U2AF2, XPO1, ZRSR2, ABL1, ACTN4, ALK, CASC5, CREBBP (CBP), DEK, ERG, ETV6, FRYL, FUS, HOXD13, JAK2, KMT2A, LNP1, MAML2, MECOM, MLF1, MN1, MNX1, NDE1, NPM1, NUP214, NUP98, PCM1, PDGFRB, PRDM16, PTPRR, RANBP2, RUNX1 (AML1), RUNX1T1, TOP1
Myeloid Malignancies
CBL, CBLB, DNMT3A, EED, ETV6, EZH2, PRPF40B, SUZ12, TET2, TP53 (p53)
Myeloproliferative Neoplasms (MPN)
ABL1, ASXL1, CALR, CSF1R, JAK2, JAK3, KAT6A, KRAS, MPL, NF1, NRAS, RB1, SETBP1, SF3B1, SH2B3, SRSF2, STAG2
Myelofibrosis
CALR, CHEK2 (RAD53), CSF1R, IDH1, IDH2, SRSF2
Other Myeloid Neoplasms
BRAF, CDKN2A (P16INK4A), CEBPA, FBXW7, HRAS, IKZF3, KLHDC8B, KMT2C, MSH6, NTRK3, PTEN, SRP72, TPMT
Other Myeloid Neoplasm Genes
BRCA1, BRCA2, BRINP3, CUX1, FAM47A, FAS, KCNK13, MYD88, PML, PRF1, SAXO2, STAT3, TERC, TNFRSF13B
Acute Leukemia of Ambiguous Lineage
ABL1, AFF1, BCR, CT45A2, ETV6, EWSR1, GPHN, KMT2A, MLLT10, MN1, NUP214, PBX1, SET, TCF3, ZNF384
Acute Lymphoblastic B Cell Leukemia
ABL1, ACTN4, AFF1, AFF3, AFF4, BCR, BTBD18, EPS15, ERG, ETV6, EWSR1, FUS, GAS7, JAK2, KMT2A, MAPRE1, MLLT1, NUP214, PAX5, PBX1, PCM1, RUNX1 (AML1), SET, SSBP2, TCF3, ZNF384
Acute Lymphoblastic T Cell Leukemia
ABL1, BCR, CASC5, ETV6, JAK2, KMT2A, MLLT1, MLLT10, AFDN, NOTCH1, NUP214, PBX1, RUNX1 (AML1), SET, STIL, TAL1, TCF3
Acute Monoblastic Leukemia
KMT2A, MLLT10, PICALM
B Cell Prolymphocytic Leukemia
MYC
Burkitt Leukemia
MYC
Lymphoblastic Leukemia
AFF1, KMT2A
Myeloproliferative Neoplasms
ABL1, ACSL6, BCR, ETV6, FGFR1, FGFR1OP, FIP1L1, FLT3, HOXA9, HOXD13, JAK2, LYN, MECOM, MLF1, MN1, NPM1, NUP98, PDGFRB, PSIP1, RARA, RUNX1 (AML1), TNIP1, ZMYM2
Plasma Cell Leukemia
MYC
T Cell Prolymphocytic Leukemia
MYC
T-Cell Acute Myelocytic Leukemia
KMT2A, MLLT10
Other Leukemias
IKZF3, PDCD1LG2, PRKG2, ROS1, SETD2

Product Resources

Detailed Target List for each Analyte
File Size: 25.13 KBLanguage: English

Resources

Brochures & Guides (4)
State-of-the-art technologies to fast-track and streamline NGS workflows
QIAseq Multimodal Analytical Technology
QIAseq Multimodal: The power of one
Supplementary Files (1)
List of gene targets for QIAseq Pan-cancer Multimodal Panel
Safety Data Sheets (1)
Certificates of Analysis (1)
Introducing the QIAseq Multimodal Human Leukemia Panel, a cutting-edge addition to our QIAseq Multimodal Panels lineup, specifically designed for NGS applications. This premium product offers unparalleled performance for researchers working with Human models. Leveraging advanced technology, the QIAseq Multimodal Human Leukemia Panel facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting NGS, or any other sophisticated analyses, this product from our QIAseq Multimodal Panels collection ensures optimal efficiency and reproducibility for Human studies. Embrace the future of research with QIAseq Multimodal Human Leukemia Panel and elevate your work to new heights.